Nanostring Technologies Return on Equity

Nanostring Technologies (NSTG) currently reports a ROE of 329.14%. That is above the Healthcare sector average of 22.01%. Use the charts on this page to explore Nanostring Technologies's ROE history and peer comparisons.

Nanostring Technologies's ROE of 329.14% is higher than the Healthcare sector average of 22.01%. That is roughly 1395.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Nanostring Technologies's current 329.14% should be judged against Healthcare norms (sector average: 22.01%) and against NSTG's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 329.14%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for Nanostring Technologies, and consider following NSTG for alerts when major investors trade the stock.

Nanostring Technologies is classified in the Healthcare sector. On ROE, it currently shows 329.14% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NSTG with unrelated industries.